Biopharmaceuticals
Oncology
News Release - June 4, 2007
Updated Overall Survival Data From Pivotal Herceptin Adjuvant Studies in HER2-Positive Breast Cancer
Source: Genentech
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.